Hypersensitivity Pneumonitis CT Patterns and Treatment
Nonfibrotic HP CT Patterns
- The American Thoracic Society recommends that diffusely distributed ground-glass opacities and mosaic attenuation are features of lung infiltration in nonfibrotic hypersensitivity pneumonitis, with a strength of evidence based on high-quality studies 1, 2
- Ill-defined, small centrilobular nodules on inspiratory images are characteristic of nonfibrotic hypersensitivity pneumonitis, according to the American College of Radiology 1, 3
- Air trapping on expiratory CT images is a typical feature of nonfibrotic hypersensitivity pneumonitis, as noted by the Fleischner Society 1
- Craniocaudal distribution is typically diffuse, sometimes with relative basal sparing in nonfibrotic hypersensitivity pneumonitis, as described by the American Thoracic Society 3
- Axial distribution is typically diffuse without central or peripheral predominance in nonfibrotic hypersensitivity pneumonitis, according to the American College of Radiology 1
Fibrotic HP CT Patterns
- Coexisting lung fibrosis and signs of bronchiolar obstruction are characteristic of fibrotic hypersensitivity pneumonitis, with a high strength of evidence based on multiple studies 1, 4
- Irregular fine or coarse reticulation with architectural distortion is a typical feature of fibrotic hypersensitivity pneumonitis, as noted by the American Thoracic Society 1
- Septal thickening with or without traction bronchiectasis in areas of ground-glass opacities is a characteristic feature of fibrotic hypersensitivity pneumonitis, according to the American College of Radiology 1
- The "three-density pattern" (also called "headcheese sign") is a highly specific pattern showing three different lung densities in fibrotic hypersensitivity pneumonitis, as described by the Fleischner Society 1, 5
- Fibrosis typically most severe in mid or mid and lower lung zones in fibrotic hypersensitivity pneumonitis, with a moderate strength of evidence based on several studies 1
- Relative basal sparing helps differentiate fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis, according to the American Thoracic Society 3
CT Acquisition Parameters for HP Diagnosis
- Noncontrast examination is recommended for hypersensitivity pneumonitis diagnosis, with a high strength of evidence based on multiple studies 1, 6
- Volumetric acquisition with submillimetric collimation is recommended for hypersensitivity pneumonitis diagnosis, according to the American College of Radiology 1
- Thin-section CT images (<1.5 mm) are recommended for hypersensitivity pneumonitis diagnosis, as noted by the American Thoracic Society 1
- Both inspiratory and expiratory acquisitions (expiratory to evaluate air trapping) are recommended for hypersensitivity pneumonitis diagnosis, with a moderate strength of evidence based on several studies 1, 5
- Recommended radiation dose is 1-3 mSv ("reduced" dose) for hypersensitivity pneumonitis diagnosis, according to the American College of Radiology 1
Diagnostic Considerations
- CT findings alone are not sufficient to make a definitive diagnosis of hypersensitivity pneumonitis, especially in fibrotic hypersensitivity pneumonitis, with a high strength of evidence based on multiple studies 5
- Integration with exposure history and clinical information is essential for hypersensitivity pneumonitis diagnosis, according to the American Thoracic Society 5
- Multidisciplinary discussion (MDD) is recommended for definitive diagnosis of hypersensitivity pneumonitis, as noted by the Fleischner Society 5
Treatment Considerations
- Avoidance of the causative antigen is recommended when identified, with a moderate strength of evidence based on several studies 1
- Corticosteroids are recommended for symptomatic disease, particularly in acute and subacute forms, according to the American Thoracic Society 1
- Immunosuppressive agents may be considered in chronic, progressive disease, with a low strength of evidence based on limited studies 1
- Lung transplantation may be considered in end-stage disease, as noted by the American College of Radiology 1
HRCT Patterns for Diagnosis of Hypersensitivity Pneumonitis
Fibrotic HP HRCT Patterns
- The American Thoracic Society recommends that the diagnosis of hypersensitivity pneumonitis on HRCT requires identifying both fibrosis patterns AND small airway disease features together, as the presence of fibrosis alone without small airway signs is indeterminate and cannot establish the diagnosis 7
- The 2020 ATS/JRS/ALAT guidelines categorize fibrotic HP into three diagnostic confidence levels based on specific HRCT features, including typical HP pattern, compatible with HP pattern, and indeterminate for HP pattern 7, 8
- Fibrosis features of typical HP pattern include irregular linear opacities/coarse reticulation with lung distortion, traction bronchiectasis and honeycombing, and distribution patterns that strongly suggest HP, such as random distribution and mid lung zone predominant 7, 8
- Small airway disease features of typical HP pattern include ill-defined centrilobular nodules and/or ground-glass opacities, mosaic attenuation, and air trapping in lobular distribution 7
Nonfibrotic HP HRCT Patterns
- The American College of Chest Physicians provides distinct criteria for nonfibrotic HP, including profuse poorly defined centrilobular nodules of ground-glass opacity, inspiratory mosaic attenuation with three-density sign, and inspiratory mosaic attenuation and air-trapping associated with centrilobular nodules 9
Critical Diagnostic Features
- The three-density pattern is a highly specific sign that shows three distinct lung densities sharply demarcated from each other, including high attenuation, lucent lung, and normal lung, and is pathognomonic when present 7
- The presence of small airway disease signs, such as centrilobular nodules, mosaic attenuation, and air trapping, is essential for the diagnosis of HP, and the absence of these features makes the HRCT indeterminate for HP, regardless of the fibrosis pattern present 7, 8
Special Considerations for Patient Context
- Fibrotic HP can still occur in patients with emphysema and pulmonary fibrosis, and should be actively considered, with the key distinguishing feature being the presence of small airway disease signs alongside the fibrosis 7, 8
HRCT Diagnostic Criteria and Technical Guidelines for Hypersensitivity Pneumonitis
1. Diagnostic Imaging Criteria for Non‑fibrotic HP
- Both parenchymal infiltration and small‑airway disease must be present for a diagnosis of non‑fibrotic hypersensitivity pneumonitis; the combination distinguishes HP from other interstitial lung diseases. (ATS/JRS/ALAT 2020 guideline – strong recommendation) 10
- Ground‑glass opacities (GGO) appear as diffusely increased attenuation that does not obscure underlying vessels. (ATS/JRS/ALAT 2020 guideline) 10, 11
- Mosaic attenuation results from patchy GGO adjacent to normal‑appearing lung, producing a patchwork of densities on inspiratory images. (ATS/JRS/ALAT 2020 guideline) 10, 12
- The distribution of these parenchymal findings is diffuse in both craniocaudal and axial planes, often with relative basal sparing. (ATS/JRS/ALAT 2020 guideline) 10
- Ill‑defined centrilobular nodules (< 5 mm) are seen on inspiratory scans and represent small‑airway involvement. (ATS/JRS/ALAT 2020 guideline) 10, 11
- Air trapping is demonstrated on expiratory CT as lobular areas of decreased attenuation, confirming bronchiolar obstruction. (ATS/JRS/ALAT 2020 guideline) 10
2. Imaging Features of Fibrotic HP
- Irregular fine or coarse reticulation with architectural distortion is the hallmark fibrotic pattern. (ATS/JRS/ALAT 2020 guideline) 10
- Traction bronchiectasis occurring within areas of GGO indicates fibrotic change. (ATS/JRS/ALAT 2020 guideline) 10
- Septal thickening may accompany reticulation. (ATS/JRS/ALAT 2020 guideline) 10
- Honeycombing can be present but is usually minimal; extensive honeycombing suggests advanced disease. (ATS/JRS/ALAT 2020 guideline) 10
- The “three‑density pattern” (high‑attenuation GGO from active inflammation, lucent lung from air trapping, and normal‑appearing lung) is pathognomonic for fibrotic HP and helps separate it from idiopathic pulmonary fibrosis. (ATS/JRS/ALAT 2020 guideline – strong recommendation) 12
- Fibrosis is most severe in mid‑ or mid‑lower lung zones with relative basal sparing, and shows no central or peripheral predominance on axial images—features that differentiate it from usual interstitial pneumonia (UIP). (ATS/JRS/ALAT 2020 guideline) 10
- Co‑existence of fibrosis and bronchiolar obstruction (e.g., centrilobular nodules or air trapping) is required for a definitive diagnosis; a UIP pattern without small‑airway disease is considered indeterminate for HP. (ATS/JRS/ALAT 2020 guideline) 10
3. Optimal HRCT Acquisition Protocol
| Parameter | Recommended Specification (ATS/JRS/ALAT 2020) |
|---|---|
| Contrast | Non‑contrast examination |
| Acquisition | Volumetric acquisition at full inspiration and separate expiratory acquisition (mandatory) |
| Collimation | Sub‑millimetric collimation with the shortest rotation time and highest pitch |
| Slice Thickness | Thin‑section images ≤ 1.5 mm, contiguous or overlapping |
| Reconstruction | High‑spatial‑frequency algorithm; iterative reconstruction if validated |
| Patient Position | Prone positioning optional to differentiate dependent attenuation |
| Radiation Dose | Recommended 1–3 mSv (reduced‑dose protocol) |
| Dose Avoidance | Strong recommendation to avoid ultra‑low‑dose CT (< 1 mSv) because critical findings may be missed |
All technical specifications are drawn from the 2020 ATS/JRS/ALAT guideline and are strongly recommended. 10, 11, 13, 14
4. Common Pitfalls and How to Avoid Them
- Missing small‑airway disease: Diagnosing HP based solely on fibrosis patterns can be erroneous; always acquire expiratory images to detect air trapping, which may be the only clue to bronchiolar involvement. (ATS/JRS/ALAT 2020 guideline) 10
- Confusing mosaic attenuation: The presence of centrilobular nodules together with mosaic attenuation strongly favors HP over vascular causes (e.g., chronic thromboembolic disease). (ATS/JRS/ALAT 2020 guideline) 10
- Misclassifying chronic fibrotic HP as UIP/IPF: Key distinguishing features include mid‑lung or upper‑lung predominance, the three‑density pattern, relative basal sparing, and evidence of small‑airway disease. (ATS/JRS/ALAT 2020 guideline) 10, 12
- Inadequate technical protocol: Using only inspiratory scans or ultra‑low‑dose protocols can miss air trapping and subtle centrilobular nodules; adhere to the full set of 2020 guideline parameters (both inspiratory and expiratory, appropriate dose, thin sections). (ATS/JRS/ALAT 2020 guideline – strong recommendation) 10, 11, 13, 14